Home  |  Contact

Cellosaurus MCF-7/2a (CVCL_0412)

[Text version]

Cell line name MCF-7/2a
Synonyms MCF-7/2A; MCF7/2a; MCF-7 clone 2A
Accession CVCL_0412
Resource Identification Initiative To cite this cell line use: MCF-7/2a (RRID:CVCL_0412)
Comments Selected for resistance to: ChEBI; CHEBI:29063; L-mimosine.
Caution: There is confusion in the literature between estrogen-independent MCF-7:2A (CVCL_4Y53), L-mimosine-resistant MCF-7/2a (CVCL_0412) and EREwtcluc transfected MCF-7-2a (CVCL_4Y54).
Sequence variations Homozygous for CDKN2A deletion (from parent cell line).
Heterozygous for PIK3CA p.Glu545Lys (c.1633G>A) (ClinVar=VCV000013655) (from parent cell line).
Disease Invasive ductal carcinoma, not otherwise specified (NCIt: C4194)
Derived from metastatic site: Pleural effusion.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_0031 (MCF-7)
Sex of cell Female
Age at sampling 69Y
Category Cancer cell line
Publications

PubMed=10766749; DOI=10.1074/jbc.M001610200
Oppenheim E.W., Nasrallah I.M., Mastri M.G., Stover P.J.
Mimosine is a cell-specific antagonist of folate metabolism.
J. Biol. Chem. 275:19268-19274(2000)

PubMed=15531579; DOI=10.1074/jbc.M410467200
Perry C., Sastry R., Nasrallah I.M., Stover P.J.
Mimosine attenuates serine hydroxymethyltransferase transcription by chelating zinc. Implications for inhibition of DNA replication.
J. Biol. Chem. 280:396-400(2005)

Cross-references
Ontologies BTO; BTO:0002270
MCCL; MCC:0000308
Other Wikidata; Q54904345
Entry history
Entry creation04-Apr-2012
Last entry update02-Jul-2020
Version number16